156 related articles for article (PubMed ID: 16914737)
1. A single base difference between Pit-1 binding sites at the hGH promoter and locus control region specifies distinct Pit-1 conformations and functions.
Shewchuk BM; Ho Y; Liebhaber SA; Cooke NE
Mol Cell Biol; 2006 Sep; 26(17):6535-46. PubMed ID: 16914737
[TBL] [Abstract][Full Text] [Related]
2. Expression of Pit-1 in nonsomatotrope cell lines induces human growth hormone locus control region histone modification and hGH-N transcription.
Hogan KA; Jefferson HS; Karschner VA; Shewchuk BM
J Mol Biol; 2009 Jul; 390(1):26-44. PubMed ID: 19427323
[TBL] [Abstract][Full Text] [Related]
3. POU1F1-mediated activation of hGH-N by deoxyribonuclease I hypersensitive site II of the human growth hormone locus control region.
Hunsaker TL; Jefferson HS; Morrison JK; Franklin AJ; Shewchuk BM
J Mol Biol; 2012 Jan; 415(1):29-45. PubMed ID: 22094313
[TBL] [Abstract][Full Text] [Related]
4. Specification of unique Pit-1 activity in the hGH locus control region.
Shewchuk BM; Liebhaber SA; Cooke NE
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11784-9. PubMed ID: 12189206
[TBL] [Abstract][Full Text] [Related]
5. Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation.
Shewchuk BM; Asa SL; Cooke NE; Liebhaber SA
J Biol Chem; 1999 Dec; 274(50):35725-33. PubMed ID: 10585453
[TBL] [Abstract][Full Text] [Related]
6. DNase I hypersensitive site II of the human growth hormone locus control region mediates an essential and distinct long-range enhancer function.
Fleetwood MR; Ho Y; Cooke NE; Liebhaber SA
J Biol Chem; 2012 Jul; 287(30):25454-65. PubMed ID: 22669946
[TBL] [Abstract][Full Text] [Related]
7. Locus control region transcription plays an active role in long-range gene activation.
Ho Y; Elefant F; Liebhaber SA; Cooke NE
Mol Cell; 2006 Aug; 23(3):365-75. PubMed ID: 16885026
[TBL] [Abstract][Full Text] [Related]
8. Distinct chromatin configurations regulate the initiation and the maintenance of hGH gene expression.
Ho Y; Shewchuk BM; Liebhaber SA; Cooke NE
Mol Cell Biol; 2013 May; 33(9):1723-34. PubMed ID: 23428872
[TBL] [Abstract][Full Text] [Related]
9. Enhancer-blocking activity is associated with hypersensitive site V sequences in the human growth hormone locus control region.
Jin Y; Oomah K; Cattini PA
DNA Cell Biol; 2011 Dec; 30(12):995-1005. PubMed ID: 21711161
[TBL] [Abstract][Full Text] [Related]
10. A defined locus control region determinant links chromatin domain acetylation with long-range gene activation.
Ho Y; Elefant F; Cooke N; Liebhaber S
Mol Cell; 2002 Feb; 9(2):291-302. PubMed ID: 11864603
[TBL] [Abstract][Full Text] [Related]
11. The human growth hormone locus control region mediates long-distance transcriptional activation independent of nuclear matrix attachment regions.
Shewchuk BM; Cooke NE; Liebhaber SA
Nucleic Acids Res; 2001 Aug; 29(16):3356-61. PubMed ID: 11504873
[TBL] [Abstract][Full Text] [Related]
12. Appearance of the pituitary factor Pit-1 increases chromatin remodeling at hypersensitive site III in the human GH locus.
Yang X; Jin Y; Cattini PA
J Mol Endocrinol; 2010 Jul; 45(1):19-32. PubMed ID: 20395397
[TBL] [Abstract][Full Text] [Related]
13. The role of the hGH locus control region in somatotrope restriction of hGH-N gene expression.
Ho Y; Liebhaber SA; Cooke NE
Mol Endocrinol; 2011 May; 25(5):877-84. PubMed ID: 21415161
[TBL] [Abstract][Full Text] [Related]
14. DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression.
Bennani-Baïti IM; Asa SL; Song D; Iratni R; Liebhaber SA; Cooke NE
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10655-60. PubMed ID: 9724759
[TBL] [Abstract][Full Text] [Related]
15. A role for A/T-rich sequences and Pit-1/GHF-1 in a distal enhancer located in the human growth hormone locus control region with preferential pituitary activity in culture and transgenic mice.
Jin Y; Surabhi RM; Fresnoza A; Lytras A; Cattini PA
Mol Endocrinol; 1999 Aug; 13(8):1249-66. PubMed ID: 10446901
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of interferon-gamma increases growth hormone expression in rat pituitary GH(3) cells].
Gong FY; Shi YF; Deng JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):619-24. PubMed ID: 12198566
[TBL] [Abstract][Full Text] [Related]
17. The juxtaposition of a promoter with a locus control region transcriptional domain activates gene expression.
Ho Y; Tadevosyan A; Liebhaber SA; Cooke NE
EMBO Rep; 2008 Sep; 9(9):891-8. PubMed ID: 18636089
[TBL] [Abstract][Full Text] [Related]
18. Repression of the prolactin promoter: a functional consequence of the heterodimerization between Pit-1 and Pit-1 beta.
Sporici RA; Hodskins JS; Locasto DM; Meszaros LB; Ferry AL; Weidner AM; Rinehart CA; Bailey JC; Mains IM; Diamond SE
J Mol Endocrinol; 2005 Oct; 35(2):317-31. PubMed ID: 16216912
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the human growth hormone gene family: possible role for Pit-1 in early stages of pituitary-specific expression and repression.
Cattini PA; Yang X; Jin Y; Detillieux KA
Neuroendocrinology; 2006; 83(3-4):145-53. PubMed ID: 17047377
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of a human POU1F1 mutation associated with isolated growth hormone deficiency: a novel etiology for IGHD.
Sobrier ML; Tsai YC; Pérez C; Leheup B; Bouceba T; Duquesnoy P; Copin B; Sizova D; Penzo A; Stanger BZ; Cooke NE; Liebhaber SA; Amselem S
Hum Mol Genet; 2016 Feb; 25(3):472-83. PubMed ID: 26612202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
